Original Article

Subject Category: Melanocytes/Melanoma

Journal of Investigative Dermatology (2009) 129, 131–138; doi:10.1038/jid.2008.193; published online 17 July 2008

In Vivo Reflectance Confocal Microscopy Enhances Secondary Evaluation of Melanocytic Lesions

The work was done in Sydney, Australia, and Modena, Italy.

Pascale Guitera1, Giovanni Pellacani2, Caterina Longo2, Stefania Seidenari2, Michelle Avramidis1 and Scott W Menzies1

  1. 1Sydney Melanoma Diagnostic Centre, Sydney Cancer Centre and Dermatology Department, Royal Prince Alfred Hospital, Faculty of Medicine, University of Sydney, Sydney, New South Wales, Australia
  2. 2Department of Dermatology, University of Modena and Reggio Emilia, Modena and Reggio Emilia, Italy

Correspondence: Scott W. Menzies, Sydney Melanoma Diagnostic Centre, Sydney Cancer Centre, Royal Prince Alfred Hospital, Camperdown, New South Wales 2050, Australia. E-mail: scott.menzies@email.cs.nsw.gov.au

Received 12 November 2007; Revised 4 March 2008; Accepted 2 April 2008; Published online 17 July 2008.

Top

Abstract

We recently described an in vivo reflectance confocal microscopy (RCM) method and our aim was to evaluate a possible additive value of this type of analysis in the management of melanocytic lesions. In two referral centers (Sydney and Modena), lesions (203 nevi and 123 melanomas (MMs) with a median Breslow thickness of 0.54 mm) were excised on the basis of clinical suspicion (history, dermoscopy examination, and/or digital monitoring). The RCM method was also trialed on a non-biopsied population of 100 lesions, which were clinically and dermoscopically diagnosed as benign nevi. All RCM and dermoscopy diagnoses were performed blinded to the histopathological diagnosis. Firstly, in the study population, a high interobserver agreement (on a subset of 90 lesions) was seen with the RCM method, which had superior specificity (68%, 95% confidence interval (95% CI): 61.1–74.3) for the diagnosis of MM compared with dermoscopy (32%, 95% CI: 25.9–38.7), while showing no difference in sensitivity (91%, 95% CI: 84.6–95.5, RCM; 88%, 95% CI: 80.7–92.6 dermoscopy). The two techniques had a weak correlation, resulting in only 2.4% of MMs being misclassified by both techniques. Diagnosis of light-colored lesions is improved by RCM (specificity 84%, 95% CI: 66.3–94.5) compared with dermoscopy (specificity 39%, 95% CI: 23.7–56.2). Secondly, the RCM method classified 100% of the non-biopsied control nevi population as benign.

Abbreviations:

95% CI, 95% confidence interval; MM, melanoma; OR, odds ratio; RCM, in vivo reflectance confocal microscopy

Extra navigation

.
ADVERTISEMENT